Showing 1 - 10 of 24,315
This paper analyzes the optimal content regulation of direct-to-consumer advertisement (DTCA) in a pharmaceutical … promote their own specific products under product DTCA, whereas they can only advertise the presence of a disease and its … typical subjective symptoms under enlightenment DTCA. The content regulation changes the nature of market competition and the …
Persistent link: https://www.econbiz.de/10012024745
Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show strong interrelations in drug prescriptions between the inpatient and outpatient sectors by using a large administrative dataset from Austria. Patients with prior hospital visits have a significantly...
Persistent link: https://www.econbiz.de/10011663278
Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show strong interrelations in drug prescriptions between the inpatient and outpatient sectors by using a large administrative dataset from Austria. Patients with prior hospital visits have a significantly...
Persistent link: https://www.econbiz.de/10011570769
In the 1990s, competition among health insurance funds (‘sickness funds’) was introduced in Germany. As one means of competition, free choice of initial health funds and subsequent switching between them was made available to all insured. Since then, the number of funds has decreased...
Persistent link: https://www.econbiz.de/10009021874
This paper examines the optimal content regulation of DTCA by comparing two forms of DTCA-product-specific and category …-specific-and identifies a key tradeoff which underlies this policy debate. Our analysis suggests that the optimal form of DTCA depends … crucially on the cost effectiveness of DTCA and the market-size distortion induced by DTCA. When the cost of advertisement is …
Persistent link: https://www.econbiz.de/10013472337
A fundamental question in pharmaceutical marketing management is: How does the effectiveness of detailing change when additional information on drugs is revealed via patients' experiences during the product lifecycle? To address this question, we develop a model of detailing and prescribing...
Persistent link: https://www.econbiz.de/10005787016
In the 1990s, competition among health insurance funds (‘sickness funds’) was introduced in Germany. As one means of competition, free choice of initial health funds and subsequent switching between them was made available to all insured. Since then, the number of funds has decreased...
Persistent link: https://www.econbiz.de/10008516757
The following is a model of psychological contracting with unmonitorable performance, implicit offers, and screening for non-performance by the announcement of the expectation of performance. It is motivated by the $250 billion prescription drug industry, which spends $19 billion per year on...
Persistent link: https://www.econbiz.de/10005109577
This paper analyzes the optimal content regulation of direct-to-consumer advertisement (DTCA) in a pharmaceutical … promote their own specific products under product DTCA, whereas they can only advertise the presence of a disease and its … typical subjective symptoms under enlightenment DTCA. The content regulation changes the nature of market competition and the …
Persistent link: https://www.econbiz.de/10012897821
Umbrella branding is a marketing practice whereby multi-product firms leverage their reputation across different product categories. This paper investigates how advertising in the market of over-the-counter (OTC) drugs affects the decision to buy prescription drugs from a promoted brand name. I...
Persistent link: https://www.econbiz.de/10012947424